The FDA has recently approved “Sinuva”, a sinus implant to treat nasal polyps. Up to 25% of patients with allergic rhino-sinusitis develop nasal polyps. The polyps can cause nasal discharge, chronic congestion, snoring, tendency to sinus infection and loss of sense of smell. Often the polyps can be treated with nasal steroid sprays and with leukotriene modifier pills such as Singular or Accolate.
But, for some patient’s surgery is the only option. Unfortunately, in many surgical patients the polyps often regrow.
Enter Sinuva, a mometasone-eluting sinus implant. Mometasone is a topical steroid found in skin creams, nasal sprays and asthma sprays. The implant is placed, often following nasal polypectomy and left in place to slowly release the mometasone. Research has shown a dramatic reduction in polyp regrowth. The main side effect was bloody nasal discharge. The cost is $1,275 per nostril.